INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in UnitedHealth Group Incorporated of Class Action Lawsuit and Upcoming Deadlines – UNH

Core Viewpoint - A class action lawsuit has been filed against UnitedHealth Group Incorporated, alleging securities fraud and unlawful business practices [2][4]. Group 1: Class Action Details - Investors are encouraged to contact Pomerantz LLP to join the class action, with a deadline of July 7, 2025, to apply as Lead Plaintiff [2][3]. - The lawsuit pertains to potential misconduct by UnitedHealth and its officers or directors [2]. Group 2: Financial Performance and Market Reaction - On April 17, 2025, UnitedHealth revised its 2025 net earnings outlook to a range of $24.65 to $25.15 per share, down from a previous guidance of $28.15 to $28.65 per share [4]. - The adjusted earnings outlook was also revised to a range of $26.00 to $26.50 per share, compared to the earlier guidance of $29.50 to $30.00 per share [4]. - Following the announcement, UnitedHealth's stock price dropped by $159.71 per share, or 27%, closing at $425.33 per share on April 18, 2025 [4].